Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Vitamins E And C, Carotenoids Do Not Lower Stroke Risk In Men, Study Finds

This article was originally published in The Tan Sheet

Executive Summary

The risk of stroke in a group of U.S. men did not seem to be substantially reduced as a result of taking supplements of vitamin E, vitamin C and specific carotenoids, Alberto Ascherio, MD, Harvard Medical/Brigham & Women's Hospital, et al., report in the June 14 Annals of Internal Medicine. The results are from a prospective observational study of stroke in 43,438 men enrolled in the Health Professionals Follow-Up Study.

You may also be interested in...



Vitamin E Cardiovascular Benefits Disputed In HOPE Study

Long-term daily vitamin E supplementation has no apparent effect on cardiovascular outcomes in high-risk individuals 55 years and older, Heart Outcomes Prevention Evaluation Study (HOPE) investigators report in the Jan. 20 New England Journal of Medicine.

Vitamin E Cardiovascular Benefits Disputed In HOPE Study

Long-term daily vitamin E supplementation has no apparent effect on cardiovascular outcomes in high-risk individuals 55 years and older, Heart Outcomes Prevention Evaluation Study (HOPE) investigators report in the Jan. 20 New England Journal of Medicine.

Vitamin E Cardiovascular Benefits Disputed In HOPE Study

Long-term daily vitamin E supplementation has no apparent effect on cardiovascular outcomes in high-risk individuals 55 years and older, Heart Outcomes Prevention Evaluation Study (HOPE) investigators report in the Jan. 20 New England Journal of Medicine.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS089976

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel